Piper Jaffray Remains on Sidelines with Sarepta (SRPT) Despite Rolling NDA For Eteplirsen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. META
2. NVDA
3. SPY
4. VRTX
5. LGND
6. ONON
7. USO
8. PSKY
9. MONC:IM
10. PTON

Go back to Piper Jaffray Remains on Sidelines with Sarepta (SRPT) Despite Rolling NDA For Eteplirsen
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 21.02 +0.88 (4.37%)
Previous Close $20.14    52 Week High $63.73 
Open $20.46    52 Week Low $8.00 
Day High $21.12    P/E N/A 
Day Low $20.19    EPS $-5.69 
Volume 389,051